Clinician pushes policy reform to tackle infectious diseases

2026-02-28 - 06:46

By Matilda Ikediobi Nigerian clinician, Ayo-Ige Ayodele, has called for the development and implementation of a comprehensive plan to strengthen Nigeria’s infectious disease systems using evidence-based public health strategies. Ayodele, who is currently undergoing advanced training in Epidemiology at the Yale School of Public Health, said although his long-term goal is to reinforce Nigeria’s disease-control frameworks, there is a need to promote community-led initiatives and improve surveillance systems to improve public health strategies. The health expert identified inadequate funding, workforce shortages, weak primary healthcare systems and unequal access to care as persistent challenges in the country’s health sector. He stressed that sustainable progress would require stronger disease surveillance systems, investment in community health workers, expanded local research capacity, and data-driven decision-making. The medical doctor, who obtained his degree from Obafemi Awolowo University, Ile-Ife, explained that his passion for public health grew during his clinical rotations in Nigeria. He said he frequently treated patients battling onchocerciasis, lymphatic filariasis, schistosomiasis and advanced HIV/AIDS. He said: “I saw firsthand the heavy burden of infectious diseases in underserved communities. I came to understand that while clinical medicine saves individuals, public health can protect entire populations.” Ayodele noted that those early experiences exposed him to the realities of poverty, stigma and fragile health systems that fuel preventable illnesses. He added that the encounters shaped his decision to pursue epidemiology, which he described as “the scientific foundation of Internal Medicine.” “Epidemiology connects clinical practice with scientific discovery helping us understand disease patterns, transmission, and the interventions that can prevent them,” he said. Speaking on his admission into Yale’s MPH Epidemiology programme, Ayodele described it as “an important milestone” that has enabled him to merge clinical medicine with advanced training in infectious disease modelling, research ethics, and global health systems. At Yale, he has participated in research aimed at reducing early mortality in advanced HIV/AIDS, including studies assessing azithromycin prophylaxis before antiretroviral therapy initiation. He has also contributed to research on the distribution of neglected tropical diseases in resource-limited areas, as well as studies examining vaccine acceptance and RSV immunoprophylaxis. “These results highlight the importance of policies that promote equitable access, affordability, community education, and effective surveillance,” he said. Highlighting the role of mentorship and collaboration in his training, he said Yale’s interdisciplinary culture has broadened his understanding of global health practice. “Yale has introduced me to advanced epidemiologic methods, infectious disease modeling, research ethics, and systems-based approaches. The mentorship culture here has shaped how I think about innovation in health,” he said. Looking ahead, Ayodele said he hopes to become an infectious disease physician-epidemiologist whose work will inform public policy and strengthen Nigeria’s response to emerging health threats. “I want to establish stronger infectious disease networks across Nigeria, develop prevention-focused programs, and mentor future clinician-scientists,” he said, adding that global training holds its greatest value when it leads to solutions tailored to the communities that need them most.